Germline TP53 pathogenic variants and breast cancer: A narrative review.
Blondeaux E, Arecco L, Punie K, Graffeo R, Toss A, De Angelis C, Trevisan L, Buzzatti G, Linn SC, Dubsky P, Cruellas M, Partridge AH, Balmaña J, Paluch-Shimon S, Lambertini M.
Blondeaux E, et al. Among authors: toss a.
Cancer Treat Rev. 2023 Mar;114:102522. doi: 10.1016/j.ctrv.2023.102522. Epub 2023 Jan 31.
Cancer Treat Rev. 2023.
PMID: 36739824
Free article.
Review.